Acute therapy consists of high-dose corticosteroids, IVIG, or plasma exchange, and long-term immunosuppression may be necessary in recurrent cases. Anti-MOG positive patients should not be treated with interferons as these may worsen the<unk>  course similar to those with NMOSD. There are also anecdotal reports against using fingolimod or Alemtuzumab.
MOG antibody disease
Selective immunoglobulin A deficiency
Hyperimmunoglobulin E syndrome
Alagille syndrome
Rh disease
Inborn errors of immunity
Chronic granulomatous disease
Wiskott–Aldrich syndrome